Clinical Trials Logo

Clinical Trial Summary

This study examines the effects of recombinant insulin like growth factor - I on body composition, glucose homeostasis, and lipids, in adults with HIV infection and signs of metabolic disease.


Clinical Trial Description

The main objectives of this study are the following:

1. Determine the effect of recombinant human insulin like growth factor-I (rhIGF-I) (generic: mecasermin) on subcutaneous adiposity in patients with HIV lipodystrophy syndrome.

2. Determine the effects of rhIGF-I on glucose homeostasis and lipids in patients with HIV lipodystrophy.

3. Determine the effects of rhIGF-I on apoptosis, mitochondria, and inflammation, in adipose tissue obtained from patients with HIV lipodystrophy. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01329744
Study type Interventional
Source University of Texas Southwestern Medical Center
Contact
Status Terminated
Phase Phase 1
Start date June 2011
Completion date June 2013

See also
  Status Clinical Trial Phase
Completed NCT00656851 - Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome N/A
Completed NCT03039491 - Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults Early Phase 1
Completed NCT04904406 - Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals Phase 4
Completed NCT00627380 - Yoga for the Management of HIV-Metabolic Syndromes Phase 4
Completed NCT00795210 - Effects of Short-term Growth Hormone in HIV-infected Patients N/A
Completed NCT01511016 - Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome N/A
Recruiting NCT04903847 - Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil Phase 4
Completed NCT01263717 - Effects of Growth Hormone Releasing Hormone in HIV N/A
Completed NCT00362440 - Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome Phase 2
Completed NCT05383456 - The Visceral Adiposity Measurement and Observation Study